Previous studies had shown an increase in TGF-β1 levels in DD; we extended these studies by examining TGF-β3, and also examined P-Smad2 as a measure for active canonical TGF-β signalling and α-SMA as a marker for myofibroblasts. This evidence concerns the gene TGFB1 and dentin dysplasia.